Launch of the IFRA 2024 Volume of Use Survey
Advocacy & Action
Government Supports Bill Toward Progress on Environmental Justice
CMP Risk Management Publications Plan for July to September 2024
DEL Bulletin LEPP No:177 & 178: Health Canada Health Product Shortage Plan and Survey Regarding Potential Regulatory Changes
New Biocides Regulations and Updated Fees
IFRA Information Letter n° 1185: Update on the Revised IFRA Policy on Furocoumarins
CMP Risk Assessment Publications Plan for July to September 2024
Extended comment period for certain proposed Hotlist changes
FDA Issues FY2023 Report on the State of Pharmaceutical Quality
DEL Bulletin 166: Health Canada’s Approach to Foreign Building Name and Addresses Listed on the Drug Establishment Licence
